LMAT

108.06

1.43% 1.52

Handel nachbörslich: 108.06

Lemaitre Vascular Inc (LMAT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

$106.54

Offen:

$107.7

24-Stunden-Volumen:

156.43K

Relative Volume:

0.85

Marktkapitalisierung:

$2.46B

Einnahmen:

$249.60M

Nettoeinkommen (Verlust:

$57.73M

KGV:

42.99

EPS:

2.5139

Netto-Cashflow:

$74.47M

1W Leistung:

+0.62%

1M Leistung:

+23.27%

6M Leistung:

+17.09%

1J Leistung:

+37.10%

1-Tages-Spanne:

$106.57

$108.74

1-Wochen-Bereich:

$105.20

$112.00

52-Wochen-Spanne:

$71.42

$115.33

Lemaitre Vascular Inc Stock (LMAT) Company Profile

Firmenname

Lemaitre Vascular Inc

Sektor

Healthcare (1118)

Branche

Medical Instruments & Supplies (58)

Telefon

781-221-2266

Adresse

63 SECOND AVENUE, BURLINGTON, MA

Mitarbeiter

655

Twitter

@LMAT_Vascular

Nächster Verdiensttermin

2025-02-24

Neueste SEC-Einreichungen

LMAT's Discussions on Twitter

Compare LMAT vs ISRG, BDX, ALC, MDLN, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LMAT Lemaitre Vascular Inc	108.06	2.43B	249.60M	57.73M	74.47M	2.5139
ISRG Intuitive Surgical Inc	472.16	170.20B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	159.36	45.41B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	77.32	38.26B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	41.46	33.33B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	230.84	33.86B	5.40B	1.49B	1.78B	10.12

Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-08-06	Hochstufung	Barrington Research	Mkt Perform → Outperform
2025-02-28	Herabstufung	Barrington Research	Outperform → Mkt Perform
2025-02-28	Herabstufung	Oppenheimer	Outperform → Perform
2025-02-13	Eingeleitet	Wells Fargo	Equal Weight
2024-10-15	Eingeleitet	Cantor Fitzgerald	Neutral
2024-08-02	Fortgesetzt	Lake Street	Buy
2024-05-31	Fortgesetzt	ROTH MKM	Buy
2024-04-26	Hochstufung	Stifel	Hold → Buy
2024-02-06	Fortgesetzt	KeyBanc Capital Markets	Sector Weight
2023-10-23	Eingeleitet	JMP Securities	Mkt Outperform
2023-09-06	Eingeleitet	Oppenheimer	Outperform
2023-08-03	Herabstufung	Jefferies	Buy → Hold
2023-05-03	Hochstufung	Barrington Research	Mkt Perform → Outperform
2022-10-28	Herabstufung	Barrington Research	Outperform → Mkt Perform
2021-09-16	Eingeleitet	Jefferies	Buy
2021-02-12	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2020-03-16	Hochstufung	Sidoti	Neutral → Buy
2019-10-24	Herabstufung	First Analysis Sec	Strong Buy → Outperform
2019-10-24	Hochstufung	Lake Street	Hold → Buy
2019-10-14	Hochstufung	First Analysis Sec	Outperform → Strong Buy
2019-07-25	Bestätigt	Barrington Research	Outperform
2019-07-25	Hochstufung	First Analysis Sec	Neutral → Outperform
2018-10-08	Hochstufung	Barrington Research	Mkt Perform → Outperform
2018-10-08	Hochstufung	ROTH Capital	Neutral → Buy
2018-06-08	Fortgesetzt	ROTH Capital	Buy
2018-04-26	Herabstufung	Stifel	Buy → Hold
2018-04-26	Hochstufung	The Benchmark Company	Hold → Buy
2017-10-27	Herabstufung	First Analysis Sec	Overweight → Equal-Weight
2017-10-27	Herabstufung	The Benchmark Company	Buy → Hold
2017-07-10	Herabstufung	Canaccord Genuity	Buy → Hold
2017-07-10	Herabstufung	The Benchmark Company	Buy → Hold
2017-03-21	Eingeleitet	First Analysis Sec	Overweight
2017-02-22	Herabstufung	Barrington Research	Outperform → Mkt Perform
2016-09-22	Herabstufung	Sidoti	Buy → Neutral
2016-07-28	Bestätigt	Barrington Research	Outperform
2016-02-25	Bestätigt	Barrington Research	Outperform

Alle ansehen

Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten

11:00 AM

Kennedy Capital Management LLC Has $18.89 Million Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat

11:00 AM

06:43 AM

3 Healthcare Stocks to Avoid in 2026: Analysis of UnderperformersNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform

06:43 AM

Mar 10, 2026

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Announces Quarterly Dividend of $0.25 - MarketBeat

Mar 10, 2026

First Trust Advisors LP Grows Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat

Mar 10, 2026

Stronger 2025 Results, Higher Dividend and Buyback Might Change The Case For Investing In LeMaitre Vascular (LMAT) - simplywall.st

Mar 10, 2026

Mar 08, 2026

Avoiding Lag: Real-Time Signals in (LMAT) Movement - Stock Traders Daily

Mar 08, 2026

LeMaitre Vascular Stock Forms Golden Cross, Signals Bullish Breakout Ahead - Markets Mojo

Mar 08, 2026

Mar 07, 2026

LeMaitre Vascular Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics - Markets Mojo

Mar 07, 2026

Is LeMaitre Vascular Inc. stock a safe haven assetTrade Exit Summary & Verified Momentum Watchlists - Naître et grandir

Mar 07, 2026

Mar 06, 2026

Is LeMaitre Vascular Inc stock showing strong momentumMarket Trend Review & Low Risk Entry Point Guides - baoquankhu1.vn

Mar 06, 2026

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Hold" from Analysts - MarketBeat

Mar 04, 2026

Mar 03, 2026

LeMaitre Vascular Experiences Revision in Stock Evaluation Amid Strong Performance Metrics - Markets Mojo

Mar 03, 2026

LeMaitre Vascular Hits New 52-Week High at $115.33, Up 46.41% - Markets Mojo

Mar 03, 2026

LMAT SEC FilingsLemaitre Vasculr 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 03, 2026